Aurora Cannabis (TSE:ACB) has released an update.
Aurora Cannabis Inc. has reported its most successful fiscal year, announcing a record $12.8 million in adjusted EBITDA for 2024 and a 21% increase in net revenue year-over-year. The company also noted a 20% growth in global medical cannabis net revenue, buoyed by acquisitions and rising sales in international markets. Aurora ended the fiscal year with a robust cash position of approximately $180 million and is on track to achieve positive free cash flow by the end of 2024.
For further insights into TSE:ACB stock, check out TipRanks’ Stock Analysis page.
